<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1665-1146</journal-id>
<journal-title><![CDATA[Boletín médico del Hospital Infantil de México]]></journal-title>
<abbrev-journal-title><![CDATA[Bol. Med. Hosp. Infant. Mex.]]></abbrev-journal-title>
<issn>1665-1146</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1665-11462018000500267</article-id>
<article-id pub-id-type="doi">10.24875/bmhim.m18000033</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Medicina supresora y medicina estimulante: una mirada penetrante de la práctica médica]]></article-title>
<article-title xml:lang="en"><![CDATA[Suppressive medicine and stimulant medicine: a penetrating view in medical practice]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Viniegra-Velázquez]]></surname>
<given-names><![CDATA[Leonardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Infantil de México Federico Gómez Unidad de Hemato-Oncología e Investigación Unidad de Investigación en Medicina Basada en Evidencias]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>75</volume>
<numero>5</numero>
<fpage>267</fpage>
<lpage>278</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1665-11462018000500267&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1665-11462018000500267&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1665-11462018000500267&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La teoría de la medicina supresora (MS) y la medicina estimulante (ME) destaca dos formas radicalmente distintas de entender la enfermedad y de enfrentarla. Para la MS es un objeto extraño o ajeno al organismo que hay que disminuir o destruir (suprimir); para la ME es un trastorno de la armonía interna que requiere fortalecer o avivar el organismo para restablecerla (estimular). En la medicina moderna, el poder de la industria de la salud favorece el predominio de la MS, por su alta rentabilidad, y la marginación de las medicinas alternativas (MA), poco rentables que, al igual que la vacunación o las terapias sustitutivas y regenerativas, son formas de ME. El efecto placebo (EP) inherente a la práctica médica, revelador de fuerzas curativas endógenas susceptibles de estimulación, da sentido a la ME y credibilidad a las MA. La dirección del EP de lo macro (psicosocial) a lo micro (físico-químico) explica su alta especificidad y ausencia de efectos secundarios. El efecto farmacológico de lo micro a lo macro, opuesto a las fuerzas endógenas, conlleva indefectiblemente efectos secundarios que requieren ulteriores supresiones y dosis repetidas indefinidamente. Se analizan equívocos de la ciencia con respecto al EP y al imponer a las MA criterios metódicos propios de la MS, que las desvirtúa, descalifica y excluye como objetos de conocimiento. Se insiste en la necesidad de reconocer la ME y rescatar las MA para la indagación, a fin de explorar sinergias, complementos o reemplazos con relación a la MS en la búsqueda del bien vivir.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: The theory of suppressive (SuM) and stimulant (StM) medicine highlights two radically different ways of understanding and coping with diseases. For SuM it is a strange or foreign object to the organism that must be diminished or destroyed (suppressed); for StM it is a disorder of internal harmony that requires strengthening or enlivening the body to re-establish it (stimulate). In modern medicine, the power in the health industry favors the predominance of SuM, because of its high profitability, and the marginalization of low-cost alternative medicines (AM) that, like vaccination or substitutive and regenerative therapies, are forms of StM. The placebo effect (PE) inherent to medical practice, revealing of endogenous curative forces susceptible to stimulation, gives meaning to StM and credibility to AM. The direction of the PE from the macro (psychosocial) to the micro (physical-chemical) explains its high specificity and absence of side effects. The pharmacological effect of the micro to the macro, opposed to the endogenous forces, inevitably entails side effects that require further suppression and indefinite repetition of doses. Scientific assertions that misunderstand PE, and impose on the AM methodical criteria of the SuM that detract, disqualify and exclude them as objects of knowledge, are analyzed. The emphasis is on the need to recognize the StM and rescue the AM for inquiry in order to explore synergies, complements or replacements in relation to the SuM, in the quest for to live well.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Medicina supresora]]></kwd>
<kwd lng="es"><![CDATA[Medicina estimulante]]></kwd>
<kwd lng="es"><![CDATA[Efecto placebo]]></kwd>
<kwd lng="es"><![CDATA[Efecto farmacológico]]></kwd>
<kwd lng="es"><![CDATA[Medicinas alternativas]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad crónica]]></kwd>
<kwd lng="en"><![CDATA[Suppressive medicine]]></kwd>
<kwd lng="en"><![CDATA[Stimulant medicine]]></kwd>
<kwd lng="en"><![CDATA[Placebo effect]]></kwd>
<kwd lng="en"><![CDATA[Pharmacological effect]]></kwd>
<kwd lng="en"><![CDATA[Alternative medicines]]></kwd>
<kwd lng="en"><![CDATA[Chronic disease]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viniegra-Velázquez]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La historia cultural de la enfermedad]]></article-title>
<source><![CDATA[Rev Invest Clin.]]></source>
<year>2008</year>
<volume>60</volume>
<page-range>527-44</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canguilhem]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<source><![CDATA[Las concepciones de R. Leriche. Lo normal y lo patológico]]></source>
<year>1978</year>
<page-range>63-71</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Siglo XXI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viniegra-Velázquez]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El orden cultural, la enfermedad y el cuidado de la salud]]></article-title>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2017</year>
<volume>74</volume>
<page-range>397-406</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leavell]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
</person-group>
<source><![CDATA[Preventive medicine for the doctor in his community. An epidemiologic approach]]></source>
<year>1953</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[McGraw Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Riaño Galán]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez Jacob]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevención cuaternaria. La contención como imperativo ético]]></article-title>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2014</year>
<volume>81</volume>
<page-range>396.e1-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viniegra-Velázquez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El bien vivir: ¿cuidado de la salud o proyecto vital? Parte I]]></article-title>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2016</year>
<volume>73</volume>
<page-range>139-46</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gérvas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Fernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso y abuso del poder médico para definir enfermedad y factor de riesgo en relación con la prevención cuaternaria en España]]></article-title>
<source><![CDATA[Gac Sanit]]></source>
<year>2006</year>
<volume>20</volume>
<numero>^sSupl. 1</numero>
<issue>^sSupl. 1</issue>
<supplement>Supl. 1</supplement>
<page-range>127-34</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zackrisson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Andersson]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Janzon]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Manjer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Garne]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow up study]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2006</year>
<volume>332</volume>
<page-range>689-92</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viniegra-Velázquez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La educación en nuestro tiempo: ¿competencia o aptitud? El caso de la medicina. Parte I]]></article-title>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2017</year>
<volume>74</volume>
<page-range>164-73</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viniegra-Velázquez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El reduccionismo científico y el control de las conciencias. Parte II]]></article-title>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2014</year>
<volume>71</volume>
<page-range>323-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ernst]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review of systematics reviews of homeopathy]]></article-title>
<source><![CDATA[Br J Clin Pharmacol]]></source>
<year>2002</year>
<volume>54</volume>
<page-range>577-82</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="book">
<collab>National Health and Medical Research Council</collab>
<source><![CDATA[NHMRC Information Paper: Evidence of effectiveness of homeopathy for treating health conditions]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Canberra ]]></publisher-loc>
<publisher-name><![CDATA[National Health and Research Council]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viniegra Velázquez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El efecto placebo. Su dimensión teórica y sus implicaciones prácticas]]></article-title>
<source><![CDATA[Ciencia]]></source>
<year>1987</year>
<volume>38</volume>
<page-range>131-46</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beecher]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pain in men wounded in battle]]></article-title>
<source><![CDATA[Ann Surg]]></source>
<year>1946</year>
<volume>123</volume>
<page-range>96-104</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beecher]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
</person-group>
<source><![CDATA[Measurement of subjective responses. Quantitative effects of drugs]]></source>
<year>1959</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Porter]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Culter]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[BY]]></given-names>
</name>
<name>
<surname><![CDATA[Reich]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pentoxifylline efficacy in the treatment of intermittent claudication multicenter controlled double blind trial with objective assessment of chronic occlusive arterial disease patients]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>1982</year>
<volume>104</volume>
<page-range>66-74</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morison]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Woodmansey]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Placebo responses in arthritis trial]]></article-title>
<source><![CDATA[Ann Rheum Dis]]></source>
<year>1961</year>
<volume>20</volume>
<page-range>179-84</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amsterdam]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New aspects of placebo response in angina pectoris]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>1969</year>
<volume>20</volume>
<page-range>249-54</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Budoff]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Zomepirac sodium in the treatment of primary dysmenorrhea syndrome]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1982</year>
<volume>307</volume>
<page-range>714-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molling]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Lockner]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Sauls]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Eisenberg]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Committed delinquent boys: the impact of perphenazine and of placebo]]></article-title>
<source><![CDATA[Arch Gen Psychiatry]]></source>
<year>1962</year>
<volume>7</volume>
<page-range>70-4</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wayne]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Placebos]]></article-title>
<source><![CDATA[Br Med J]]></source>
<year>1956</year>
<volume>2</volume>
<page-range>157-62</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leslie]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ethics and practice of placebo therapy]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>1954</year>
<volume>16</volume>
<page-range>854-7</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Maria]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Craven]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Heffernan]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[McIntosh]]></surname>
<given-names><![CDATA[TK]]></given-names>
</name>
<name>
<surname><![CDATA[Grindlinger]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Naloxone versus placebo in treatment of septic shock]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1985</year>
<volume>325</volume>
<page-range>1363-5</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palmer]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The hypotensive action of Rauwolfia serpentina and reserpine: a double hidden placebo study of ambulatory patients with hypertension]]></article-title>
<source><![CDATA[Am Pract Digest Treat]]></source>
<year>1955</year>
<volume>6</volume>
<page-range>1323-6</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abbot]]></surname>
<given-names><![CDATA[FK]]></given-names>
</name>
<name>
<surname><![CDATA[Mack]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wolf]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The action of banthine on the stomach and duodenum of man with observations on the effects of placebos]]></article-title>
<source><![CDATA[Gastroenterol]]></source>
<year>1952</year>
<volume>20</volume>
<page-range>249-54</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Bissel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Blood sugar lowering effects of chloropropamide and tolbutamide. A double blind cooperative study]]></article-title>
<source><![CDATA[Diabetes]]></source>
<year>1965</year>
<volume>14</volume>
<page-range>650-4</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zubieta]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Stohler]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neurobiological mechanisms of placebo responses]]></article-title>
<source><![CDATA[Ann N Y Acad Sci]]></source>
<year>2009</year>
<volume>1156</volume>
<page-range>198-210</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peciña]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zubieta]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular mechanisms of placebo responses in humans]]></article-title>
<source><![CDATA[Mol Psychiatry]]></source>
<year>2015</year>
<volume>20</volume>
<page-range>416-23</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viniegra-Velázquez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Anticipación y ontogenia. Penetrando el proceso vital: más allá de la adaptación, el azar y la selección natural. Teoría de la interiorización del entorno y la anticipación]]></source>
<year>2012</year>
<page-range>341-64</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B30">
<label>30.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ader]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Behaviorally conditioned immune suppression]]></article-title>
<source><![CDATA[Psychos Med]]></source>
<year>1975</year>
<volume>37</volume>
<page-range>333-6</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Woods]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Kulkosky]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Classically conditioned changes of blood glucose level]]></article-title>
<source><![CDATA[Psychos Med]]></source>
<year>1976</year>
<volume>38</volume>
<page-range>201-5</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Honderich]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Reductionism. The Oxford Companion of Philosophy]]></source>
<year>2005</year>
<page-range>793-5</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<label>33.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goldberg]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Medicina alternativa. La guía definitiva]]></source>
<year>1999</year>
<page-range>37-481</page-range><publisher-loc><![CDATA[California ]]></publisher-loc>
<publisher-name><![CDATA[Future Med Publish Inc]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
